# Handoff Report — Explorer 1 (Directory and Community Researcher)

## 1. Observation
The following direct observations were made from the project workspace files:
* In `APP_DESCRIPTION.md` (lines 4–7), Gainhelm is defined as an:
  > "Agent-First, Context-Driven AI dispatcher for field service teams... Technicians receive and accept dispatch offers via native text messages (SMS/WhatsApp) without downloading or logging into any app."
* In `docs/marketing/gainhelm-promotion-brief.md` (line 94), the SaaSHub verification check states:
  > "The live SaaSHub guidance on that page says submitted products go through approval and explicitly rejects `Landing pages with an email form for a waiting list` and `Products that are not released yet will be rejected immediately`"
* In `docs/marketing/gainhelm-promotion-brief.md` (line 68), the BetaList check states:
  > "A Gainhelm draft submission was created/advanced at `https://betalist.com/submissions/167383`... The flow reached `https://betalist.com/submissions/167383/wizard/submit`, but the visible final options were paid only: Premium `$299`, Standard `$99`, and Lite `$39`. Submission is blocked on paid package approval..."
* In `docs/marketing/gainhelm-promotion-brief.md` (line 342), TheSaaSDir check states:
  > "...the free tier explicitly says `Badge required`, and step 4 requires adding a dofollow badge snippet to the website..."
* In `docs/marketing/gainhelm-promotion-brief.md` (lines 279, 324, 421), forms such as Business-Software.com, AppInsight, and ConTechFinder are gated behind `CAPTCHA`, `reCAPTCHA`, or `Cloudflare Turnstile` verification tokens.

---

## 2. Logic Chain
1. **Fact**: Gainhelm is currently a prototype landing page with an early-access waitlist and has no public login/app launch (`APP_DESCRIPTION.md`).
2. **Inference**: Directories that reject pre-launch/waitlist products (e.g., SaaSHub) will immediately reject Gainhelm if submitted today.
3. **Fact**: Several directories (e.g., Launching Next, SaaSHunt AI, The Next AI, SmartBizTools, FreeAIO, Conversion Gems, ShowMySites, FirstUsers) have public no-login/no-CAPTCHA submission forms that successfully accepted Gainhelm's early-access payload.
4. **Inference**: Immediate organic listing actions must be focused on these waitlist-friendly directories (Phase 1).
5. **Fact**: Key directories (e.g., AlternativeTo, Product Hunt, Capterra/G2, SaaSHub) require either domain-verified email accounts, OAuth authentication, or a fully launched product.
6. **Inference**: Listing on these platforms must be deferred until post-launch/beta stages once domain emails are active (Phase 2).
7. **Conclusion**: A staged directory submission playbook (Phase 1 immediate, Phase 2 deferred) is the optimal path for Gainhelm's organic footprint.

---

## 3. Caveats
* **External Verification**: No live external web queries were executed during this investigation (as per the `CODE_ONLY` network constraint). Traffic sizes and guidelines are derived from internal project documentation (`gainhelm-promotion-brief.md` and `gainhelm-omnichannel-visibility-roadmap.md`) verified on 2026-05-25/2026-05-26.
* **Authentication Policies**: Platform login requirements or fee structures may change without notice.

---

## 4. Conclusion
We have compiled and analyzed **15 directories and platforms** suitable for Gainhelm. The detailed profiles, asset specifications, and submission guidelines have been written to the final output file:
`/home/ubuntuadmin/projects/ai-field-service-dispatcher/.agents/explorer_distribution_1/analysis.md`

This analysis is ready to be utilized by the worker agent to construct the final distribution database and execution playbook.

---

## 5. Verification Method
* **File Inspection**: Verify the presence and correctness of the compiled registry and playbook by viewing the output file:
  `view_file(AbsolutePath="/home/ubuntuadmin/projects/ai-field-service-dispatcher/.agents/explorer_distribution_1/analysis.md")`
* **Content Match**: Verify that the directories in the table align with the status records in `gainhelm-promotion-brief.md`.
